Istaiti, M.; Becker-Cohen, M.; Dinur, T.; Revel-Vilk, S.; Zimran, A.
Real-Life Experience with Oral Eliglustat in Patients with Gaucher Disease Previously Treated with Enzyme Replacement Therapy. J. Clin. Med. 2022, 11, 6265.
https://doi.org/10.3390/jcm11216265
AMA Style
Istaiti M, Becker-Cohen M, Dinur T, Revel-Vilk S, Zimran A.
Real-Life Experience with Oral Eliglustat in Patients with Gaucher Disease Previously Treated with Enzyme Replacement Therapy. Journal of Clinical Medicine. 2022; 11(21):6265.
https://doi.org/10.3390/jcm11216265
Chicago/Turabian Style
Istaiti, Majdolen, Michal Becker-Cohen, Tama Dinur, Shoshana Revel-Vilk, and Ari Zimran.
2022. "Real-Life Experience with Oral Eliglustat in Patients with Gaucher Disease Previously Treated with Enzyme Replacement Therapy" Journal of Clinical Medicine 11, no. 21: 6265.
https://doi.org/10.3390/jcm11216265
APA Style
Istaiti, M., Becker-Cohen, M., Dinur, T., Revel-Vilk, S., & Zimran, A.
(2022). Real-Life Experience with Oral Eliglustat in Patients with Gaucher Disease Previously Treated with Enzyme Replacement Therapy. Journal of Clinical Medicine, 11(21), 6265.
https://doi.org/10.3390/jcm11216265